PsiOxus and Parker Institute collaborate on virus-based gene therapy to treat solid tumors Nov. 16, 2018
New AR degrader ARD-61 demonstrates efficacy in models of castration-resistant prostate cancer Nov. 16, 2018
Phase III trial of fruquintinib in third-line NSCLC does not meet primary endpoint of OS Nov. 16, 2018
Isofol initiates pivotal phase III study of arfolitixorin in metastatic colorectal cancer Nov. 16, 2018
Baicalein regulates proliferation and chemosensitivity in HCC by upregulating miR-181a-5p Nov. 16, 2018
RSS